These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25849320)

  • 1. FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications.
    Gassen NC; Hartmann J; Zannas AS; Kretzschmar A; Zschocke J; Maccarrone G; Hafner K; Zellner A; Kollmannsberger LK; Wagner KV; Mehta D; Kloiber S; Turck CW; Lucae S; Chrousos GP; Holsboer F; Binder EB; Ising M; Schmidt MV; Rein T
    Mol Psychiatry; 2016 Feb; 21(2):277-89. PubMed ID: 25849320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans.
    Gassen NC; Hartmann J; Zschocke J; Stepan J; Hafner K; Zellner A; Kirmeier T; Kollmannsberger L; Wagner KV; Dedic N; Balsevich G; Deussing JM; Kloiber S; Lucae S; Holsboer F; Eder M; Uhr M; Ising M; Schmidt MV; Rein T
    PLoS Med; 2014 Nov; 11(11):e1001755. PubMed ID: 25386878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine.
    Gassen NC; Fries GR; Zannas AS; Hartmann J; Zschocke J; Hafner K; Carrillo-Roa T; Steinbacher J; Preißinger SN; Hoeijmakers L; Knop M; Weber F; Kloiber S; Lucae S; Chrousos GP; Carell T; Ising M; Binder EB; Schmidt MV; Rüegg J; Rein T
    Sci Signal; 2015 Nov; 8(404):ra119. PubMed ID: 26602018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model.
    Lim YW; Yoon SY; Choi JE; Kim SM; Lee HS; Choe H; Lee SC; Kim DH
    Biochem Biophys Res Commun; 2010 Apr; 395(2):207-12. PubMed ID: 20362550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes.
    de Sousa RT; Zanetti MV; Talib LL; Serpa MH; Chaim TM; Carvalho AF; Brunoni AR; Busatto GF; Gattaz WF; Machado-Vieira R
    J Psychiatr Res; 2015 Mar; 62():78-83. PubMed ID: 25691093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
    Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.
    Skurk C; Maatz H; Rocnik E; Bialik A; Force T; Walsh K
    Circ Res; 2005 Feb; 96(3):308-18. PubMed ID: 15662032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway.
    Yang W; Nam K; Ju JH; Lee KM; Oh S; Shin I
    Cell Signal; 2014 Oct; 26(10):2096-106. PubMed ID: 24975844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3β.
    Martin L; Page G; Terro F
    Neurochem Int; 2011 Aug; 59(2):235-50. PubMed ID: 21672577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium chloride and staurosporine potentiate the accumulation of phosphorylated glycogen synthase kinase 3β/Tyr216, resulting in glycogen synthase kinase 3β activation in SH-SY5Y human neuroblastoma cell lines.
    Noël A; Barrier L; Rinaldi F; Hubert C; Fauconneau B; Ingrand S
    J Neurosci Res; 2011 May; 89(5):755-63. PubMed ID: 21360572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of citalopram on chronic stress-induced depressive-like behavior in rats through GSK3β/β-catenin activation in the medial prefrontal cortex.
    Chen YC; Tan QR; Dang W; Wang HN; Zhang RB; Li ZY; Lin H; Liu R
    Brain Res Bull; 2012 Jul; 88(4):338-44. PubMed ID: 22472057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau overexpression in transgenic mice induces glycogen synthase kinase 3beta and beta-catenin phosphorylation.
    Shim SB; Lim HJ; Chae KR; Kim CK; Hwang DY; Jee SW; Lee SH; Sin JS; Leem YH; Lee SH; Cho JS; Lee HH; Choi SY; Kim YK
    Neuroscience; 2007 May; 146(2):730-40. PubMed ID: 17337327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells.
    Joshi MB; Ivanov D; Philippova M; Erne P; Resink TJ
    FASEB J; 2007 Oct; 21(12):3083-95. PubMed ID: 17485554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells.
    Zhao L; Miao HC; Li WJ; Sun Y; Huang SL; Li ZY; Guo QL
    Mol Carcinog; 2016 May; 55(5):778-92. PubMed ID: 25945460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK3β negatively regulates oligodendrocyte differentiation and myelination in vivo.
    Azim K; Butt AM
    Glia; 2011 Apr; 59(4):540-53. PubMed ID: 21319221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK3β/β-catenin signaling is correlated with the differentiation of glioma cells induced by wogonin.
    Wang Y; Zhang Y; Qian C; Cai M; Li Y; Li Z; You Q; Wang Q; Hu R; Guo Q
    Toxicol Lett; 2013 Oct; 222(2):212-23. PubMed ID: 23872260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis.
    Farago M; Dominguez I; Landesman-Bollag E; Xu X; Rosner A; Cardiff RD; Seldin DC
    Cancer Res; 2005 Jul; 65(13):5792-801. PubMed ID: 15994955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase-3 phosphorylation, T-cell factor signaling activation, and cell morphology change following stimulation of thromboxane receptor alpha.
    Yan W; Tai HH
    J Pharmacol Exp Ther; 2006 Apr; 317(1):267-74. PubMed ID: 16352701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
    Wang Y; Lam JB; Lam KS; Liu J; Lam MC; Hoo RL; Wu D; Cooper GJ; Xu A
    Cancer Res; 2006 Dec; 66(23):11462-70. PubMed ID: 17145894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.